After Court Loss, Biotech Company Removes Enzyme
The decision came only a day after a federal judge ruled that Spezyme Ethyl infringed a patent owned by Genencor’s main rival, Danish biotech company Novozymes A/S.
“We are very pleased with the decision but we are obviously annoyed by the harm the patent infringement has caused on our market for biofuel enzymes,” said Novozymes’ general counsel Kristian Merser. “It’s very satisfactory that the...
To view the full article, register now.